- $17.26bn
- $19.45bn
- $2.86bn
Revvity Inc reports results for the quarter ended in September 30 - Earnings Summary
Revvity falls after cutting 2024 revenue forecast
Revvity cuts 2024 revenue forecast amid biotech spending slowdown
U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics
U.S. STOCKS ON THE MOVE-United Airlines, Morgan Stanley, Autodesk
U.S. STOCKS ON THE MOVE-Gold miners, J.B. Hunt, Cisco Systems
Bernstein expects a 'not so scary' Q3 for US life sciences firms
U.S. STOCKS ON THE MOVE-Bank of Marin Bancorp, ON Semiconductor, Walt Disney
U.S. STOCKS ON THE MOVE-Ventyx Biosciences, McDonald's, Pinterest
Revvity Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Tesla, Guardant Health, Abbott Laboratories
Revvity raises 2024 profit forecast on medical equipment demand; shares rise
Revvity climbs after raising annual profit forecast
Brief: Revvity Q2 Revenue USD 691.685 Million Vs. IBES Estimate USD 690.4 Million
Revvity Inc expected to post earnings of $1.12 a share - Earnings Preview
Brief: Bionano Announces Software Marketing Agreement With Revvity For Newborn Sequencing Research
U.S. RESEARCH ROUNDUP- Domino's Pizza, HCA Healthcare, HCA Healthcare
U.S. STOCKS ON THE MOVE-3M, Phibro Animal Health, copper miners
Revvity Inc reports results for the quarter ended in January - Earnings Summary